Intra-articular injection of triamcinolone acetonide releasing biomaterial microspheres inhibits pain and inflammation in an acute arthritis model

Inflammation of the synovium and joint capsule is a main driver of pain in an osteoarthritic (OA) joint. Triamcinolone acetonide (TAA) is a classical corticosteroid that reduces synovitis and alleviates pain, albeit transiently. Biomaterial-based local TAA release may prolong the suppression of pain...

Full description

Bibliographic Details
Main Authors: Imke Rudnik-Jansen, Karin Schrijver, Nina Woike, Anna Tellegen, Sabine Versteeg, Pieter Emans, George Mihov, Jens Thies, Niels Eijkelkamp, Marianna Tryfonidou, Laura Creemers
Format: Article
Language:English
Published: Taylor & Francis Group 2019-01-01
Series:Drug Delivery
Subjects:
Online Access:http://dx.doi.org/10.1080/10717544.2019.1568625
id doaj-9e7b74ab86124f0b86ca8010f97063b2
record_format Article
spelling doaj-9e7b74ab86124f0b86ca8010f97063b22020-11-25T01:35:17ZengTaylor & Francis GroupDrug Delivery1071-75441521-04642019-01-0126122623610.1080/10717544.2019.15686251568625Intra-articular injection of triamcinolone acetonide releasing biomaterial microspheres inhibits pain and inflammation in an acute arthritis modelImke Rudnik-Jansen0Karin Schrijver1Nina Woike2Anna Tellegen3Sabine Versteeg4Pieter Emans5George Mihov6Jens Thies7Niels Eijkelkamp8Marianna Tryfonidou9Laura Creemers10University Medical Center UtrechtUniversity Medical Center UtrechtDSM Biomedical B.VUtrecht UniversityUniversity Medical Center Utrecht, Utrecht UniversityMaastricht University Medical Center UtrechtDSM Biomedical B.VDSM Biomedical B.VUniversity Medical Center Utrecht, Utrecht UniversityUtrecht UniversityUniversity Medical Center UtrechtInflammation of the synovium and joint capsule is a main driver of pain in an osteoarthritic (OA) joint. Triamcinolone acetonide (TAA) is a classical corticosteroid that reduces synovitis and alleviates pain, albeit transiently. Biomaterial-based local TAA release may prolong the suppression of pain without the need for multiple injections. Polylactic-co-glycolic acid (PLGA) formulations of TAA prolong OA pain relief to a limited extent. A novel polyesteramide (PEA) microsphere platform allows for extended release in the OA joint for over 3 months. To evaluate their effect on pain and inflammation, TAA-loaded microspheres were intra-articularly delivered to the knee joint in a rat model of acute arthritis induced by intra-articular injection of streptococcal cell wall peptidoglycan-polysaccharide (PGPS) and subsequent flare-ups by intravenous PGPS injections. PEA-loaded microspheres were benchmarked with TAA-loaded PLGA microspheres and bolus TAA injection. TAA treatments were injected intra-articularly before the first induced flare-up. TAA-loaded PEA and PLGA microspheres reduced joint swelling and signs of pain-like behavior over the entire study period, as assessed by weight bearing and referred mechanical hypersensitivity, whereas bolus suspension was effective for a shorter time period. TAA-loaded PEA microspheres reduced lameness to a greater extent than TAA-loaded PLGA microspheres. In conclusion, a single intra-articular injection of TAA-loaded PEA microspheres reduced joint swelling and induced longer pain relief compared to bolus injection. Hence relief of inflammation and pain by PEA-based delivery of TAA may prove to be effective and durable.http://dx.doi.org/10.1080/10717544.2019.1568625arthritismicrospherespolyesteramidepolylactic-co-glycolic acidsynovitistriamcinolone acetonide
collection DOAJ
language English
format Article
sources DOAJ
author Imke Rudnik-Jansen
Karin Schrijver
Nina Woike
Anna Tellegen
Sabine Versteeg
Pieter Emans
George Mihov
Jens Thies
Niels Eijkelkamp
Marianna Tryfonidou
Laura Creemers
spellingShingle Imke Rudnik-Jansen
Karin Schrijver
Nina Woike
Anna Tellegen
Sabine Versteeg
Pieter Emans
George Mihov
Jens Thies
Niels Eijkelkamp
Marianna Tryfonidou
Laura Creemers
Intra-articular injection of triamcinolone acetonide releasing biomaterial microspheres inhibits pain and inflammation in an acute arthritis model
Drug Delivery
arthritis
microspheres
polyesteramide
polylactic-co-glycolic acid
synovitis
triamcinolone acetonide
author_facet Imke Rudnik-Jansen
Karin Schrijver
Nina Woike
Anna Tellegen
Sabine Versteeg
Pieter Emans
George Mihov
Jens Thies
Niels Eijkelkamp
Marianna Tryfonidou
Laura Creemers
author_sort Imke Rudnik-Jansen
title Intra-articular injection of triamcinolone acetonide releasing biomaterial microspheres inhibits pain and inflammation in an acute arthritis model
title_short Intra-articular injection of triamcinolone acetonide releasing biomaterial microspheres inhibits pain and inflammation in an acute arthritis model
title_full Intra-articular injection of triamcinolone acetonide releasing biomaterial microspheres inhibits pain and inflammation in an acute arthritis model
title_fullStr Intra-articular injection of triamcinolone acetonide releasing biomaterial microspheres inhibits pain and inflammation in an acute arthritis model
title_full_unstemmed Intra-articular injection of triamcinolone acetonide releasing biomaterial microspheres inhibits pain and inflammation in an acute arthritis model
title_sort intra-articular injection of triamcinolone acetonide releasing biomaterial microspheres inhibits pain and inflammation in an acute arthritis model
publisher Taylor & Francis Group
series Drug Delivery
issn 1071-7544
1521-0464
publishDate 2019-01-01
description Inflammation of the synovium and joint capsule is a main driver of pain in an osteoarthritic (OA) joint. Triamcinolone acetonide (TAA) is a classical corticosteroid that reduces synovitis and alleviates pain, albeit transiently. Biomaterial-based local TAA release may prolong the suppression of pain without the need for multiple injections. Polylactic-co-glycolic acid (PLGA) formulations of TAA prolong OA pain relief to a limited extent. A novel polyesteramide (PEA) microsphere platform allows for extended release in the OA joint for over 3 months. To evaluate their effect on pain and inflammation, TAA-loaded microspheres were intra-articularly delivered to the knee joint in a rat model of acute arthritis induced by intra-articular injection of streptococcal cell wall peptidoglycan-polysaccharide (PGPS) and subsequent flare-ups by intravenous PGPS injections. PEA-loaded microspheres were benchmarked with TAA-loaded PLGA microspheres and bolus TAA injection. TAA treatments were injected intra-articularly before the first induced flare-up. TAA-loaded PEA and PLGA microspheres reduced joint swelling and signs of pain-like behavior over the entire study period, as assessed by weight bearing and referred mechanical hypersensitivity, whereas bolus suspension was effective for a shorter time period. TAA-loaded PEA microspheres reduced lameness to a greater extent than TAA-loaded PLGA microspheres. In conclusion, a single intra-articular injection of TAA-loaded PEA microspheres reduced joint swelling and induced longer pain relief compared to bolus injection. Hence relief of inflammation and pain by PEA-based delivery of TAA may prove to be effective and durable.
topic arthritis
microspheres
polyesteramide
polylactic-co-glycolic acid
synovitis
triamcinolone acetonide
url http://dx.doi.org/10.1080/10717544.2019.1568625
work_keys_str_mv AT imkerudnikjansen intraarticularinjectionoftriamcinoloneacetonidereleasingbiomaterialmicrospheresinhibitspainandinflammationinanacutearthritismodel
AT karinschrijver intraarticularinjectionoftriamcinoloneacetonidereleasingbiomaterialmicrospheresinhibitspainandinflammationinanacutearthritismodel
AT ninawoike intraarticularinjectionoftriamcinoloneacetonidereleasingbiomaterialmicrospheresinhibitspainandinflammationinanacutearthritismodel
AT annatellegen intraarticularinjectionoftriamcinoloneacetonidereleasingbiomaterialmicrospheresinhibitspainandinflammationinanacutearthritismodel
AT sabineversteeg intraarticularinjectionoftriamcinoloneacetonidereleasingbiomaterialmicrospheresinhibitspainandinflammationinanacutearthritismodel
AT pieteremans intraarticularinjectionoftriamcinoloneacetonidereleasingbiomaterialmicrospheresinhibitspainandinflammationinanacutearthritismodel
AT georgemihov intraarticularinjectionoftriamcinoloneacetonidereleasingbiomaterialmicrospheresinhibitspainandinflammationinanacutearthritismodel
AT jensthies intraarticularinjectionoftriamcinoloneacetonidereleasingbiomaterialmicrospheresinhibitspainandinflammationinanacutearthritismodel
AT nielseijkelkamp intraarticularinjectionoftriamcinoloneacetonidereleasingbiomaterialmicrospheresinhibitspainandinflammationinanacutearthritismodel
AT mariannatryfonidou intraarticularinjectionoftriamcinoloneacetonidereleasingbiomaterialmicrospheresinhibitspainandinflammationinanacutearthritismodel
AT lauracreemers intraarticularinjectionoftriamcinoloneacetonidereleasingbiomaterialmicrospheresinhibitspainandinflammationinanacutearthritismodel
_version_ 1725067350207627264